Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image stem cells

Ghost Organs, Stem Cells and Frankenstein’s Transplant Technology

By Saara Akhtar

As the interest in 3D bioprinting is sky-rocketing, it seems as though the limelight has illuminated a bigger problem for the technology that may be solved by the use of “ghost organs.” 3D bioprinting uses living cells to create models of organs and tissues. These lab-grown organs could be potentially created from adult pluripotent stem cells (cells with the capacity to differentiate many different cells).Thus, there is a possibility to mass-produce organs for transplantation.However, bioprinting faces problems; we currently do not have the technology to adequately replicate the infinite number of processes that are necessary to differentiate a stem cell. However, only a general understanding of how to activate the processes is required and it seems as though a much older biotechnology can take better advantage of this fact. “Ghost organs,” or, decellularized organs are simply what is left of the organ once we take out the cells. The white extracellular matrix, or ECM, of an organ acts as the scaffolding onto which cells adhere to in order to form the organ.

In 2007. Drs. Doris Taylor and Harald Ott, in a laboratory at the University of Minnesota, found a way to preserve the basic structure of a heart to enable stem cells to naturally adhere to it and eventually grow into a fully functioning organ. Taylor and Ott were able to completely remove the cells from a rat’s heart so that all that was left was the ECM. They then placed the “ghost heart” into a bioreactor with stem cells from other lab rats and within ten days a brand new rat heart was formed. A few days later the heart was beating.

Miromatrix Medical gained a full license for the technology from the University of Minnesota in 2010 and their first ECM device (FDA approved) will start selling in September. The future of the technology seems vast and impressive; it is suspected to not only provide transplant organs but to help improve wound healing post-surgery and provide the foundations for new technologies in regenerative medicine.

Click here for more information.

 

By Admin@gbi|2016-06-16T19:20:39+00:00August 11th, 2014|News-Articles|0 Comments

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Admin@gbi

Avatar

Related Posts

  • Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Gallery

    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024

  • AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    Gallery

    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics

  • A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    Gallery

    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD

  • Jonathan D. Moreno Ph.D. Keynote Speaker
    Jonathan D. Moreno Ph.D. Keynote Speaker
    Gallery

    Jonathan D. Moreno Ph.D. Keynote Speaker

  • Jeanne F. Loring Ph.D. Keynote Speaker
    Jeanne F. Loring Ph.D. Keynote Speaker
    Gallery

    Jeanne F. Loring Ph.D. Keynote Speaker

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area